Organovo Stock (NASDAQ:ONVO)


RevenueOwnershipFinancialsChart

Previous Close

$0.46

52W Range

$0.43 - $2.05

50D Avg

$0.54

200D Avg

$0.87

Market Cap

$7.16M

Avg Vol (3M)

$96.64K

Beta

0.61

Div Yield

-

ONVO Company Profile


Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

20

IPO Date

Feb 14, 2012

Website

ONVO Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 21Mar 20Mar 19
Grant$500.00K--
Products And Services-$2.06M$2.33M

Fiscal year ends in Mar 24 | Currency in USD

ONVO Financial Summary


Mar 24Mar 23Mar 22
Revenue$109.00K$370.00K$1.50M
Operating Income$-15.09M$-17.73M$-11.48M
Net Income$-14.67M$-17.26M$-11.45M
EBITDA$-15.09M$-17.46M$-11.34M
Basic EPS$-1.60$-1.98$-1.32
Diluted EPS$-1.60$-1.98$-1.32

Fiscal year ends in Mar 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 19May 23, 19 | 5:05 PM
Q3 19Feb 07, 19 | 8:47 PM
Q2 19Nov 08, 18 | 10:13 PM

Peer Comparison


TickerCompany
DDD3D Systems Corporation
SSYSStratasys Ltd.
MTLSMaterialise NV
VJETvoxeljet AG
PRLBProto Labs, Inc.